Wright WE - Search Results

1

Oligonucleotide conjugate GRN163L targeting human telomerase as potential anticancer and antimetastatic agent.

Gryaznov SM, Jackson S, Dikmen G, Harley C, Herbert BS, Wright WE, Shay JW. Gryaznov SM, et al. Among authors: wright we. Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1577-9. doi: 10.1080/15257770701547271. Nucleosides Nucleotides Nucleic Acids. 2007. PMID: 18066830

2

The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines.

Joseph I, Tressler R, Bassett E, Harley C, Buseman CM, Pattamatta P, Wright WE, Shay JW, Go NF. Joseph I, et al. Among authors: wright we. Cancer Res. 2010 Nov 15;70(22):9494-504. doi: 10.1158/0008-5472.CAN-10-0233. Epub 2010 Nov 9. Cancer Res. 2010. PMID: 21062983

3

Telomerase in cancer and aging.

Granger MP, Wright WE, Shay JW. Granger MP, et al. Among authors: wright we. Crit Rev Oncol Hematol. 2002 Jan;41(1):29-40. doi: 10.1016/s1040-8428(01)00188-3. Crit Rev Oncol Hematol. 2002. PMID: 11796230 Review.

4

Telomerase: a target for cancer therapeutics.

Shay JW, Wright WE. Shay JW, et al. Among authors: wright we. Cancer Cell. 2002 Oct;2(4):257-65. doi: 10.1016/s1535-6108(02)00159-9. Cancer Cell. 2002. PMID: 12398889 Free article. Review.

5

Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.

Herbert BS, Gellert GC, Hochreiter A, Pongracz K, Wright WE, Zielinska D, Chin AC, Harley CB, Shay JW, Gryaznov SM. Herbert BS, et al. Among authors: wright we. Oncogene. 2005 Aug 4;24(33):5262-8. doi: 10.1038/sj.onc.1208760. Oncogene. 2005. PMID: 15940257

6

In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.

Dikmen ZG, Gellert GC, Jackson S, Gryaznov S, Tressler R, Dogan P, Wright WE, Shay JW. Dikmen ZG, et al. Among authors: wright we. Cancer Res. 2005 Sep 1;65(17):7866-73. doi: 10.1158/0008-5472.CAN-05-1215. Cancer Res. 2005. PMID: 16140956

7

Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer.

Gellert GC, Dikmen ZG, Wright WE, Gryaznov S, Shay JW. Gellert GC, et al. Among authors: wright we. Breast Cancer Res Treat. 2006 Mar;96(1):73-81. doi: 10.1007/s10549-005-9043-5. Epub 2005 Dec 1. Breast Cancer Res Treat. 2006. PMID: 16319992

8

Antiadhesive effects of GRN163L--an oligonucleotide N3'->P5' thio-phosphoramidate targeting telomerase.

Jackson SR, Zhu CH, Paulson V, Watkins L, Dikmen ZG, Gryaznov SM, Wright WE, Shay JW. Jackson SR, et al. Among authors: wright we. Cancer Res. 2007 Feb 1;67(3):1121-9. doi: 10.1158/0008-5472.CAN-06-2306. Cancer Res. 2007. PMID: 17283146

9

Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.

Dikmen ZG, Wright WE, Shay JW, Gryaznov SM. Dikmen ZG, et al. Among authors: wright we. J Cell Biochem. 2008 May 15;104(2):444-52. doi: 10.1002/jcb.21635. J Cell Biochem. 2008. PMID: 18044713

10

The effects of telomerase inhibition on prostate tumor-initiating cells.

Marian CO, Wright WE, Shay JW. Marian CO, et al. Among authors: wright we. Int J Cancer. 2010 Jul 15;127(2):321-31. doi: 10.1002/ijc.25043. Int J Cancer. 2010. PMID: 19908230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters